Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A

Recognition for Danoff, Murrell and Noah

Physician News

Dudley Danoff, MD, discussed his new book before a large crowd at the Medical Library, Zuri A. Murrell, MD, spoke to a church congregation about colorectal cancer, and Mark S. Noah, MD, will become the local governor of the American College of Physicians.

» Read more

Meetings and Events

Grand Rounds

Click here to view upcoming grand rounds.

Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - April 2016 (PDF)  


Do you know of a significant event in the life of a medical staff member? Please let us know, and we'll post these milestones in Medical Staff Pulse. Also, feel free to submit comments on milestones, and we'll post the comments in the next issue. Click here to submit your milestones and comments.

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

New Type of HPV Test Available

The Cedars-Sinai Molecular Pathology Laboratory has announced the availability of the real­-time PCR cobas HPV Test from Roche Diagnostics. The test is performed on the fully automated cobas 4800 System, for delivery of trustworthy results with a rapid turnaround time.

The cobas HPV Test individually identifies genotypes 16 and 18, the two highest­-risk human papillomavirus genotypes responsible for more than 70 percent of cervical cancer cases, while simultaneously detecting 12 other high-risk HPV genotypes (HPV types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68).

One test, in one run, from one patient sample delivers three results:

  • HPV16: (positive/negative)
  • HPV18: (positive/negative)
  • Other HR HPV (positive/negative)

Genotype is included in the HPV high-risk screening test at no additional cost. Reflex testing for HPV types 16 and 18 is no longer required.

There will be no change to the HPV high-risk screening test ordering or cost.

If you have questions about this new method and the laboratory's internal validation studies, please call the laboratory at 310-423-5326.